Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Researchers at the University of California, Davis have developed a system and method for accurately extracting fetal photoplethysmography information from mixed maternal-fetal signals obtained non-invasively through the maternal abdomen.

Researchers at the University of California, Davis have developed technology that enables enhanced growth and colonization of beneficial gut bacteria through bacterial expression of heterologous alpha-fucosidases which target human milk oligosaccharides (HMOs), promoting a healthy gut microbiome.

Researchers at the University of California, Davis have developed alacto-oligosaccharide (GOS) formulations selectively promote growth of beneficial Bifidobacteria species by tailoring oligosaccharide chain lengths.

Brief description not available

Brief description not available

Brief description not available

Researchers at the University of California, Davis have developed recombinant fusion protein compositions that inhibit pathological angiogenesis by targeting VEGF165-KDR interactions to treat cancers and related diseases.

Brief description not available

Researchers at the University of California, Davis have developed a peptide nucleic acid-based system enabling precise and customizable delivery of antigens, adjuvants, and targeting molecules for improved cancer immunotherapy.

Brief description not available

Researchers at the University of California, Davis have developed novel serotonin receptor modulators designed as mixed 5-HT2A/2C partial agonists that demonstrate promising disease-modifying potential for Parkinson’s Disease with improved safety and efficacy.

Researchers at the University of California, Davis have developed a novel class of compounds for modulating serotonin receptors, offering potential treatment for various psychiatric and neurological disorders without inducing hallucinogenic effects.

Researchers at the University of California, Davis have developed a nanoreactor that allows for accurate measurements of radiation dose even in the vicinity of other chemicals.

A breakthrough one-wire EEG cap with embedded electrode chips provides ultra-sensitive, noise-immune, wide-band brain signal acquisition. It enables non-invasive, real-time, high-resolution recording using dry electrodes, ideal for wearable and clinical neuro-technology applications.